{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:27:57Z","timestamp":1790803677132,"version":"4.1.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,12,6]],"date-time":"2019-12-06T00:00:00Z","timestamp":1575590400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001170","name":"Cancer Council Western Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001170","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000884","name":"Cancer Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000884","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.celrep.2019.12.013","type":"journal-article","created":{"date-parts":[[2020,1,21]],"date-time":"2020-01-21T10:37:52Z","timestamp":1579603072000},"page":"714-724.e5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":84,"title":["Remodeling of Metastatic Vasculature Reduces Lung Colonization and Sensitizes Overt Metastases to Immunotherapy"],"prefix":"10.1016","volume":"30","author":[{"given":"Bo","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Johansson-Percival","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Backhouse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel Yin Foo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana","family":"Hamzah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Ganss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2019.12.013_bib1","doi-asserted-by":"crossref","first-page":"17450","DOI":"10.1073\/pnas.1114518108","article-title":"Targeted nanoparticle enhanced proapoptotic peptide as potential therapy for glioblastoma","volume":"108","author":"Agemy","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2019.12.013_bib2","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1038\/mt.2013.191","article-title":"Proapoptotic peptide-mediated cancer therapy targeted to cell surface p32","volume":"21","author":"Agemy","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.celrep.2019.12.013_bib3","doi-asserted-by":"crossref","first-page":"eaak9679","DOI":"10.1126\/scitranslmed.aak9679","article-title":"Combined antiangiogenic and anti-PD-L1 therapy stimulates tumor immunity through HEV formation","volume":"9","author":"Allen","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.celrep.2019.12.013_bib4","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1038\/s41591-018-0197-1","article-title":"Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma","volume":"24","author":"Amaria","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2019.12.013_bib5","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.cell.2018.09.018","article-title":"Evolution of metastases in space and time under immune selection","volume":"175","author":"Angelova","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2019.12.013_bib6","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1056\/NEJMoa1111097","article-title":"Bevacizumab added to neoadjuvant chemotherapy for breast cancer","volume":"366","author":"Bear","year":"2012","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.celrep.2019.12.013_bib7","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1158\/2159-8290.CD-15-0944","article-title":"Suppression of metastases using a new lymphocyte checkpoint target for cancer immunotherapy","volume":"6","author":"Blake","year":"2016","journal-title":"Cancer Discov."},{"key":"10.1016\/j.celrep.2019.12.013_bib8","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1038\/s41591-018-0198-0","article-title":"Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma","volume":"24","author":"Blank","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2019.12.013_bib9","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S1470-2045(13)70335-8","article-title":"Adjuvant bevacizumab-containing therapy in triple-negative breast cancer (BEATRICE): primary results of a randomised, phase 3 trial","volume":"14","author":"Cameron","year":"2013","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.celrep.2019.12.013_bib10","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.ccell.2016.10.006","article-title":"Inhibition of the glycolytic activator PFKFB3 in endothelium induces tumor vessel normalization, impairs metastasis, and improves chemotherapy","volume":"30","author":"Cantelmo","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2019.12.013_bib11","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/j.immuni.2019.04.010","article-title":"Intratumoral activity of the CXCR3 chemokine system is required for the efficacy of anti-PD-1 therapy","volume":"50","author":"Chow","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2019.12.013_bib12","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/S1470-2045(12)70509-0","article-title":"Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial","volume":"13","author":"de Gramont","year":"2012","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.celrep.2019.12.013_bib13","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s10585-015-9704-7","article-title":"Anti-metastatic activity of the tumor vascular targeting agent NGR-TNF","volume":"32","author":"Di Matteo","year":"2015","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.celrep.2019.12.013_bib14","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/cam4.105","article-title":"Vessel co-option in primary human tumors and metastases: an obstacle to effective anti-angiogenic treatment?","volume":"2","author":"Donnem","year":"2013","journal-title":"Cancer Med."},{"key":"10.1016\/j.celrep.2019.12.013_bib15","doi-asserted-by":"crossref","first-page":"8012","DOI":"10.1021\/acsnano.5b01552","article-title":"Spatiotemporal targeting of a dual-ligand nanoparticle to cancer metastasis","volume":"9","author":"Doolittle","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.celrep.2019.12.013_bib16","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s10555-015-9586-9","article-title":"The challenge of targeting metastasis","volume":"34","author":"Fidler","year":"2015","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.celrep.2019.12.013_bib17","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1056\/NEJMoa1716078","article-title":"Neoadjuvant PD-1 blockade in resectable lung cancer","volume":"378","author":"Forde","year":"2018","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.celrep.2019.12.013_bib18","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/s41573-018-0007-y","article-title":"Approaches to treat immune hot, altered and cold tumours with combination immunotherapies","volume":"18","author":"Galon","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.celrep.2019.12.013_bib19","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S1359-6101(03)00031-5","article-title":"LIGHT-HVEM signaling and the regulation of T\u00a0cell-mediated immunity","volume":"14","author":"Granger","year":"2003","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.celrep.2019.12.013_bib20","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/nature05760","article-title":"Mediators of vascular remodelling co-opted for sequential steps in lung metastasis","volume":"446","author":"Gupta","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2019.12.013_bib21","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/nature06868","article-title":"Vascular normalization in Rgs5-deficient tumours promotes immune destruction","volume":"453","author":"Hamzah","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2019.12.013_bib22","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/path.5080","article-title":"Vascular targeting of LIGHT normalizes blood vessels in primary brain cancer and induces intratumoural high endothelial venules","volume":"245","author":"He","year":"2018","journal-title":"J.\u00a0Pathol."},{"key":"10.1016\/j.celrep.2019.12.013_bib23","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1084\/jem.20091846","article-title":"Resistance to antiangiogenic therapy is directed by vascular phenotype, vessel stabilization, and maturation in malignant melanoma","volume":"207","author":"Helfrich","year":"2010","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.celrep.2019.12.013_bib24","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1038\/ncomms2856","article-title":"Primary tumours modulate innate immune signalling to create pre-metastatic vascular hyperpermeability foci","volume":"4","author":"Hiratsuka","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2019.12.013_bib25","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S1535-6108(03)00273-3","article-title":"Progressive vascular changes in a transgenic mouse model of squamous cell carcinoma","volume":"4","author":"Hoffman","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2019.12.013_bib26","doi-asserted-by":"crossref","first-page":"7529","DOI":"10.1158\/0008-5472.CAN-08-4382","article-title":"Pulmonary vascular destabilization in the premetastatic phase facilitates lung metastasis","volume":"69","author":"Huang","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.celrep.2019.12.013_bib27","doi-asserted-by":"crossref","first-page":"17561","DOI":"10.1073\/pnas.1215397109","article-title":"Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy","volume":"109","author":"Huang","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2019.12.013_bib28","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.cell.2017.07.025","article-title":"Heterogeneous tumor-immune microenvironments among differentially growing metastases in an ovarian cancer patient","volume":"170","author":"Jim\u00e9nez-S\u00e1nchez","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2019.12.013_bib29","first-page":"3","article-title":"More than a scaffold: stromal modulation of tumor immunity","volume":"1865","author":"Johansson","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.celrep.2019.12.013_bib30","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1016\/j.celrep.2015.12.004","article-title":"Intratumoral LIGHT restores pericyte contractile properties and vessel integrity","volume":"13","author":"Johansson-Percival","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2019.12.013_bib31","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/ni.3836","article-title":"De novo induction of intratumoral lymphoid structures and vessel normalization enhances immunotherapy in resistant tumors","volume":"18","author":"Johansson-Percival","year":"2017","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.celrep.2019.12.013_bib32","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S1535-6108(03)00271-X","article-title":"Stage-specific vascular markers revealed by phage display in a mouse model of pancreatic islet tumorigenesis","volume":"4","author":"Joyce","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2019.12.013_bib33","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.celrep.2015.01.035","article-title":"Targeting vascular pericytes in hypoxic tumors increases lung metastasis via angiopoietin-2","volume":"10","author":"Keskin","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2019.12.013_bib34","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nm.2072","article-title":"Real-time imaging reveals the single steps of brain metastasis formation","volume":"16","author":"Kienast","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2019.12.013_bib35","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1172\/JCI94674","article-title":"Endothelial Tie1-mediated angiogenesis and vascular abnormalization promote tumor progression and metastasis","volume":"128","author":"La Porta","year":"2018","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.celrep.2019.12.013_bib36","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1038\/s41467-019-09878-4","article-title":"Collagen-rich airway smooth muscle cells are a metastatic niche for tumor colonization in the lung","volume":"10","author":"Lee","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2019.12.013_bib37","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.ccell.2016.09.011","article-title":"Characteristics and significance of the pre-metastatic niche","volume":"30","author":"Liu","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2019.12.013_bib38","doi-asserted-by":"crossref","first-page":"9719","DOI":"10.1074\/jbc.M412862200","article-title":"Kruppel-like factor 4 abrogates myocardin-induced activation of smooth muscle gene expression","volume":"280","author":"Liu","year":"2005","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.celrep.2019.12.013_bib39","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1158\/2159-8290.CD-16-0577","article-title":"Improved efficacy of neoadjuvant compared to adjuvant immunotherapy to eradicate metastatic disease","volume":"6","author":"Liu","year":"2016","journal-title":"Cancer Discov."},{"key":"10.1016\/j.celrep.2019.12.013_bib40","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3389\/fimmu.2014.00047","article-title":"Role of the lymphotoxin\/LIGHT system in the development and maintenance of reticular networks and vasculature in lymphoid tissues","volume":"5","author":"Lu","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celrep.2019.12.013_bib41","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1172\/JCI121985","article-title":"Aspirin blocks formation of metastatic intravascular niches by inhibiting platelet-derived COX-1\/thromboxane A2","volume":"129","author":"Lucotti","year":"2019","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.celrep.2019.12.013_bib42","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.cell.2009.01.020","article-title":"Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization","volume":"136","author":"Mazzone","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2019.12.013_bib43","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1038\/nm.4400","article-title":"KLF4-dependent perivascular cell plasticity mediates pre-metastatic niche formation and metastasis","volume":"23","author":"Murgai","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2019.12.013_bib44","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.cell.2008.01.046","article-title":"TGFbeta primes breast tumors for lung metastasis seeding through angiopoietin-like 4","volume":"133","author":"Padua","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2019.12.013_bib45","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ccr.2009.01.027","article-title":"Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis","volume":"15","author":"P\u00e0ez-Ribes","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2019.12.013_bib46","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.ccell.2016.10.018","article-title":"Normalization of tumor vessels by Tie2 activation and Ang2 inhibition enhances drug delivery and produces a favorable tumor microenvironment","volume":"30","author":"Park","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2019.12.013_bib47","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/nrc.2017.6","article-title":"Pre-metastatic niches: organ-specific homes for metastases","volume":"17","author":"Peinado","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.celrep.2019.12.013_bib48","first-page":"571","article-title":"Immunoscintigraphic detection of the ED-B domain of fibronectin, a marker of angiogenesis, in patients with cancer","volume":"9","author":"Santimaria","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.celrep.2019.12.013_bib49","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1365-2559.2007.02800.x","article-title":"Distinct angiogenic and non-angiogenic growth patterns of lung metastases from renal cell carcinoma","volume":"51","author":"Sardari Nia","year":"2007","journal-title":"Histopathology"},{"key":"10.1016\/j.celrep.2019.12.013_bib50","doi-asserted-by":"crossref","first-page":"eaak9670","DOI":"10.1126\/scitranslmed.aak9670","article-title":"Dual angiopoietin-2 and VEGFA inhibition elicits antitumor immunity that is enhanced by PD-1 checkpoint blockade","volume":"9","author":"Schmittnaegel","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.celrep.2019.12.013_bib51","doi-asserted-by":"crossref","first-page":"4359","DOI":"10.1158\/0008-5472.CAN-16-0485","article-title":"Incipient melanoma brain metastases instigate astrogliosis and neuroinflammation","volume":"76","author":"Schwartz","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.celrep.2019.12.013_bib52","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.ccell.2014.11.005","article-title":"Postsurgical adjuvant tumor therapy by combining anti-angiopoietin-2 and metronomic chemotherapy limits metastatic growth","volume":"26","author":"Srivastava","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2019.12.013_bib53","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/path.4464","article-title":"Mechanism of tumour vascularization in experimental lung metastases","volume":"235","author":"Szabo","year":"2015","journal-title":"J.\u00a0Pathol."},{"key":"10.1016\/j.celrep.2019.12.013_bib54","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1056\/NEJMoa1111065","article-title":"Neoadjuvant chemotherapy and bevacizumab for HER2-negative breast cancer","volume":"366","author":"von Minckwitz","year":"2012","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.celrep.2019.12.013_bib55","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.ccell.2018.03.005","article-title":"Emerging concepts for immune checkpoint blockade-based combination therapies","volume":"33","author":"Zappasodi","year":"2018","journal-title":"Cancer Cell"}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124719316626?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124719316626?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T10:50:11Z","timestamp":1761907811000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211124719316626"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S2211124719316626"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2019.12.013","relation":{},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Remodeling of Metastatic Vasculature Reduces Lung Colonization and Sensitizes Overt Metastases to Immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2019.12.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Author(s).","name":"copyright","label":"Copyright"}]}}